Pages that link to "Q28487756"

The following pages link to The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity (Q28487756):

Displaying 22 items.

• Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy (Q28082536) (← links)
• LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells (Q33648588) (← links)
• MYC expression in concert with BCL2 and BCL6 expression predicts outcome in Chinese patients with diffuse large B-cell lymphoma, not otherwise specified (Q34000188) (← links)
• A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis (Q34398390) (← links)
• Systematic analysis of time-series gene expression data on tumor cell-selective apoptotic responses to HDAC inhibitors (Q34413200) (← links)
• Novel HDAC inhibitors exhibit pre-clinical efficacy in lymphoma models and point to the importance of CDKN1A expression levels in mediating their anti-tumor response (Q35741605) (← links)
• Targeting Histone Deacetylases in Diseases: Where Are We? (Q35821728) (← links)
• The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways (Q36157305) (← links)
• PU.1-Bim axis is involved in Trichostatin A-induced apoptosis in murine pro-B lymphoma FL5.12 cells (Q38756171) (← links)
• Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies (Q38811147) (← links)
• Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer (Q38819019) (← links)
• Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents (Q38840351) (← links)
• Anti-tumor activity of the combination of bendamustine with vorinostat in diffuse large B-cell lymphoma cells. (Q38862949) (← links)
• Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines. (Q38882017) (← links)
• Histone acetyltransferase-deficient p300 mutants in diffuse large B cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth (Q39023825) (← links)
• A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma (Q40690632) (← links)
• Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode (Q41514200) (← links)
• The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells. (Q42277834) (← links)
• MicroRNA-21 regulates the viability and apoptosis of diffuse large B-cell lymphoma cells by upregulating B cell lymphoma-2. (Q42675856) (← links)
• Vorinostat and metformin sensitize EGFR-TKI resistant NSCLC cells via BIM-dependent apoptosis induction (Q47162428) (← links)
• Variable Responses of MYC Translocation Positive Lymphoma Cell Lines To Different Combinations of Novel Agents: Impact of BCL2 Family Protein Expression. (Q64974176) (← links)
• Role of HDACs in normal and malignant hematopoiesis (Q92475777) (← links)